Skip to main content
Premium Trial:

Request an Annual Quote



In the 09-20-04 issue of BioInform, a quote in the article, “Bayer Spin-off Teams with Physiomics to Develop ‘Virtual Tumor’ for Drug Dosage Testing,” implied that Entelos does not offer a drug delivery model as part of its services. The company said that it has indeed incorporated drug delivery models into its disease models.

In the 09-27-04 issue of BioInform, the Expression Profile Q&A incorrectly listed Frank Brown’s affiliation as Johnson & Johnson’s Pharmaceutical Research Institute instead of Johnson & Johnson Pharmaceutical Research & Development.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.